Atlas Trials

First-in-Human Study to Evaluate AMG 579 in Healthy Subjects and Patients With Stable Schizophrenia

Clinical trial NCT01568203 · TERMINATED

Trial details

NCT number
NCT01568203
Sponsor
Amgen
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Schizophrenia
Start date
2011-09-01
Primary completion
2012-06-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.